home / stock / bctxf / bctxf news

BCTXF News and Press, BriaCell Therapeutics From 04/27/20

Stock Information
Company Name: BriaCell Therapeutics
Stock Symbol: BCTXF
Market: OTC
Website: briacell.com
Menu
BCTXF BCTXF Quote BCTXF Short BCTXF News BCTXF Articles BCTXF Message Board
Get BCTXF Alerts

News, Short Squeeze, Breakout and More Instantly...
BCTXF - BriaCell Files Patent Application for Novel Therapeutics for Cancer

BERKELEY, Calif., and VANCOUVER, British Columbia, April 27, 2020 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (“BriaCell” or the “Company”) (TSX-V:BCT) (OTCQB:BCTXF), a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced...
BCTXF - Stocks To Watch: Tech Powerhouses Lead Earnings Blitz

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

BCTXF - BriaCell Files New Provisional Patent Application for Antibody-Based Treatment of Infectious Diseases

BERKELEY, Calif., and VANCOUVER, British Columbia, April 21, 2020 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (“BriaCell” or the “Company”) (TSX-V:BCT) (OTCQB:BCTXF), a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced...

BCTXF - UPDATE - BriaCell Files Coronavirus Immunotherapy Patent

BERKELEY, Calif. and VANCOUVER, British Columbia, April 14, 2020 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (“BriaCell” or the “Company”) (TSX-V:BCT) (OTCQB:BCTXF), a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced ...
BCTXF - BriaCell Announces Proposed Public Offering in the United States and Listing on NASDAQ

THIS PRESS RELEASE IS NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES BERKELEY, Calif., and VANCOUVER, British Columbia, Feb. 21, 2020 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF) , a clinical-stage...

BCTXF - BriaCell Therapeutics (BCTXF) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow

The following slide deck was published by BriaCell Therapeutics Corp. in conjunction with this Read more ...

BCTXF - BriaCell Therapeutics Corp. Announces Share Consolidation

BERKELEY, Calif. and VANCOUVER, British Columbia, Dec. 24, 2019 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF) , a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast cancer, announces that...
BCTXF - BriaCell to Present at Biotech Showcase(TM) 2020 in San Francisco

BERKELEY, Calif. and VANCOUVER, British Columbia, Dec. 17, 2019 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF) , a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer, announces it...

BCTXF - BriaCell Announces Clinical Data as Presented at the 2019 San Antonio Breast Cancer Symposium®

Safety and early efficacy data were presented on December 12 th at 6:00 p.m. ET from the clinical trials of Bria-IMT™ in combination with immune checkpoint inhibitors in advanced breast cancer: Continued additive or synergistic activity observed in combination study of Bri...

BCTXF - BriaCell to Present Clinical Findings at the 2019 San Antonio Breast Cancer Symposium® December 12th and 13th

Safety and early efficacy data to be presented from clinical trial of Bria-IMT™ in combination with immune checkpoint inhibitors in advanced breast cancer: Bria-IMT™ in combination with pembrolizumab (KEYTRUDA ® ; by Merck & Co., Inc.); Bria-IMT™...
Previous 10 Next 10